Feasibilities and outcomes of patients treated with simultaneous prostate biopsy and general urological surgeries.

Autor:	Su R; Comprehensive Urogenital Cancer Center, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.; Ningbo Clinical Research Center for Urological Disease, Ningbo, Zhejiang 3315010, P.R. China.; Department of Urology, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.; Yi-Huan Genitourinary Cancer Group, Ningbo, Zhejiang 315010, P.R. China., Pan JF; Comprehensive Urogenital Cancer Center, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.; Medical School, Ningbo University, Ningbo, Zhejiang 315211, P.R. China., Huang RD; Comprehensive Urogenital Cancer Center, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.; Medical School, Ningbo University, Ningbo, Zhejiang 315211, P.R. China., Tao ZL; Comprehensive Urogenital Cancer Center, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.; Medical School, Ningbo University, Ningbo, Zhejiang 315211, P.R. China., Yu CL; Ningbo Clinical Research Center for Urological Disease, Ningbo, Zhejiang 3315010, P.R. China., Jiang JH; Ningbo Clinical Research Center for Urological Disease, Ningbo, Zhejiang 3315010, P.R. China.; Department of Urology, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China., Ma Q; Comprehensive Urogenital Cancer Center, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.; Ningbo Clinical Research Center for Urological Disease, Ningbo, Zhejiang 3315010, P.R. China.; Yi-Huan Genitourinary Cancer Group, Ningbo, Zhejiang 315010, P.R. China.; Translational Research Laboratory for Urology, The Key Laboratory of Ningbo City, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
Jazyk:	angličtina
Zdroj:	Experimental and therapeutic medicine [Exp Ther Med] 2022 Nov 24; Vol. 25 (1), pp. 31. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2023).
DOI:	10.3892/etm.2022.11729
Abstrakt:	The present single-center retrospective clinical real-world study aimed to assess the feasibility and outcomes of patients who underwent simultaneous prostate biopsy and general urological surgeries. The medical records of 49 patients who underwent prostate biopsy and general urological surgeries simultaneously from October 2016 to June 2019 were retrospectively reviewed. Patients' outcomes were evaluated 3 days, 1 month and 6 months after biopsy. Of the 49 biopsy cases, 41 were treated by transurethral prostatectomy, two by ureteroscopic lithotripsy, two by laparoscopic renal cyst decortication, two by cystostomy and two by ureteral stent extraction. The overall detection rate of clinically significant prostate cancer was 22.4%. The rate in patients with a prostate imaging reporting and data system (PI-RADS) score of 4-5 was 100%, while in cases with a PI-RADS score of <3 it was 7.1%. Postoperative complications within 3 days included hematuria in 39 (79.6%) cases, fever in three (6.1%) cases and hematochezia in two (4.1%) cases. There was no significant difference in the incidence of hematuria between the transrectal and transperineal approaches; however, the overall incidence of complications was significantly reduced after switching from a transrectal approach to a transperineal approach. No complications were observed after 1 or 6 months. In summary, combining simultaneous prostate biopsy to general urological surgeries is a safe and feasible approach. The transperineal approach has a lower incidence of complications. This method may benefit certain patients who are concurrently undergoing general urological surgeries and are under suspicion of prostate cancer in real-world clinical practice. Competing Interests: The authors declare that they have no competing interests. (Copyright © 2020, Spandidos Publications.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu